A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis.

Abstract

Bone metastasis is the most common distant relapse in breast cancer. The identification of key proteins involved in the osteotropic phenotype would represent a major step toward the development of new prognostic markers and therapeutic improvements. The aim of this study was to characterize functional phenotypes that favor bone metastasis in human breast cancer. We used the human breast cancer cell line MDA-MB-231 and its osteotropic BO2 subclone to identify crucial proteins in bone metastatic growth. We identified 31 proteins, 15 underexpressed and 16 overexpressed, in BO2 cells compared with parental cells. We employed a network-modeling approach in which these 31 candidate proteins were prioritized with respect to their potential in metastasis formation, based on the topology of the protein-protein interaction network and differential expression. The protein-protein interaction network provided a framework to study the functional relationships between biological molecules by attributing functions to genes whose functions had not been characterized. The combination of expression profiles and protein interactions revealed an endoplasmic reticulum-thiol oxidoreductase, ERp57, functioning as a hub that retained four down-regulated nodes involved in antigen presentation associated with the human major histocompatibility complex class I molecules, including HLA-A, HLA-B, HLA-E, and HLA-F. Further analysis of the interaction network revealed an inverse correlation between ERp57 and vimentin, which influences cytoskeleton reorganization. Moreover, knockdown of ERp57 in BO2 cells confirmed its bone organ-specific prometastatic role. Altogether, ERp57 appears as a multifunctional chaperone that can regulate diverse biological processes to maintain the homeostasis of breast cancer cells and promote the development of bone metastasis.

• Authors: Naiara Santana-Codina, Rafael Carretero, Rebeca Sanz-Pamplona, Teresa Cabrera, Emre Guney, Baldo Oliva, Philippe Clezardin, Omar E Olarte, Pablo Loza-Alvarez, Andrés Méndez-Lucas, Jose Carlos Perales, Angels Sierra
• Journal: Molecular & cellular proteomics : MCP (Mol Cell Proteomics) Vol. 12 Issue 8 Pg. 2111-25 (Aug 2013) ISSN: 1535-9484 [Electronic] United States
• PMID: 23625662 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Histocompatibility Antigens Class I
• Proteome
• Vimentin
• Protein Disulfide-Isomerases
• PDIA3 protein, human

Topics

• Animals
• Bone Neoplasms (metabolism, secondary)
• Breast Neoplasms (metabolism, pathology)
• Cell Line, Tumor
• Female
• Histocompatibility Antigens Class I (metabolism)
• Humans
• Mice
• Mice, SCID
• Neoplasm Metastasis
• Protein Disulfide-Isomerases (metabolism)
• Protein Interaction Mapping
• Proteome
• Transcriptome
• Vimentin (metabolism)